Emerging drugs for the treatment of diabetic nephropathy-Reference-Cited by-同舟云学术

Emerging drugs for the treatment of diabetic nephropathy

Published:2022-10-02 Issue:4 Volume:27 Page:417-430
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Kim Yoon Kook¹,Ning Xinyuan¹,Munir Kashif M.¹,Davis Stephen N.²

Affiliation:

1. Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Center for Diabetes and Endocrinology, Baltimore, MD, USA

2. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2022.2155632

Reference100 articles.

1. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease

2. Diabetic Kidney Disease: A Report From an ADA Consensus Conference

3. US Renal Data System 2011 Annual Data Report

4. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

5. Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compositional Analysis and Network Pharmacological Strategy for the Treatment of Diabetic Kidney Disease by Shengjiang Powder Based on UHPLC-Q-TOF-MS;Natural Product Communications;2024-09

2. A review on animal and plant proteins in regulating diabetic kidney disease: Mechanism of action and future perspectives;Journal of Functional Foods;2024-08

3. Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy;Biomedicine & Pharmacotherapy;2024-06

4. The clinical efficacy, outcomes and quality of life of diabetic disease patients treated with dapagliflozin;Medicover Journal of Medicine;2024-04

5. (+)-Catechin ameliorates diabetic nephropathy injury by inhibiting endoplasmic reticulum stress-related NLRP3-mediated inflammation;Food & Function;2024